December 21, 2014 11:05 AM ET

Healthcare Equipment and Supplies

Company Overview of MicroCHIPS, Inc.

Company Overview

MicroCHIPS, Inc. develops and tests intelligent implantable drug delivery devices and biosensors for people with chronic conditions. The company offers a delivery device for PTH(1-34)/teriparatide, an anabolic agent for the treatment of osteoporosis to deliver precise doses at prescribed intervals and overcome the compliance limitations associated with injectable drug delivery. It also provides Continuous Glucose Monitor, a long-term implanted monitor for diabetes to wirelessly deliver continuous glucose measurements. The company was incorporated in 1999 and is headquartered in Lexington, Massachusetts.

128 Spring Street

Suite 310

Lexington, MA 02421

United States

Founded in 1999





Key Executives for MicroCHIPS, Inc.

Chief Executive Officer and Director
Age: 50
President and Chief Operating Officer
Executive Chairman
Co-Founder and Director
Age: 58
Compensation as of Fiscal Year 2014.

MicroCHIPS, Inc. Key Developments

MicroCHIPS, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 09:00 AM

MicroCHIPS, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 09:00 AM. Venue: The Palace Hotel, San Francisco, CA 94105, United States. Speakers: Cheryl R. Blanchard, Chief Executive Officer and Director.

MicroCHIPS, Inc. Announces Management Changes

MicroCHIPS, Inc. announced that its Board of Directors has appointed Cheryl R. Blanchard, Ph.D., as Chief Executive Officer and member of the Board of Directors effective immediately. Blanchard was formerly Senior Vice President and Chief Scientific Officer of Zimmer, Inc. Blanchard joins MicroCHIPS at a time when the company is preparing for the next stage of commercialization for its implantable drug delivery devices, with a near-term focus on applications for women's health. As the former chief scientific officer and general manager of the biologics business at a global medical device company, Cheryl brings a skill set critical for MicroCHIPS to commercialize its products. Blanchard replaces Bradley W. Paddock, who was appointed interim CEO in December 2013. He has accepted a role as General Manager, Stryker Spine. Blanchard has extensive experience in the medical device and biologics sectors. For the past 12 years, Blanchard served in roles of increasing responsibility at Zimmer, Inc. Her roles at Zimmer included leadership of research and development, clinical, quality and regulatory affairs, and health economics. She was also a member of Zimmer's executive committee and developed and led the biologics business at Zimmer through disciplined execution of an R&D pipeline coupled with significant partnering and business development activities.

Similar Private Companies By Industry

Company Name Region
American Immuno Tech, LLC United States
Blue Ocean Biomedical LLC United States
Zynex Medical, Inc. United States
Laurane Medical, LLC United States
DJO Finance LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MicroCHIPS, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at